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Tbjective: We sought to compare the efficacy of conventional pulmonary artery
anding with that of FloWatch pulmonary artery banding.
ethods: Forty consecutive infants underwent conventional pulmonary artery band-
ng (n  20; mean age, 1.8  1.5 months; mean weight, 3.7  0.7 kg) or FloWatch
ulmonary artery banding (n  20; mean age, 2.6  1.3 months; mean weight,
.1  0.8 kg). Indications were preparation for biventricular repair in 16 of 20
nfants, univentricular repair in 2 of 20 infants, and left ventricular retraining in 2 of
0 infants in the conventional pulmonary artery banding group versus 13 of 20, 5 of
0, and 2 of 20 infants, respectively, in the FloWatch pulmonary artery banding
roup. Twelve of 20 infants required preoperative mechanical ventilation in the
onventional pulmonary artery banding group (mean duration, 3.3  4.3 days)
ersus preoperative mechanical ventilation required by 14 of 20 in the FloWatch
ulmonary artery banding group (mean duration, 17.5  19.0 days; P  .005).
esults: There were 3 early and 2 late deaths after conventional pulmonary artery
anding (mean follow-up, 10.8  9.6 months; range, 1–33 months) versus no early
nd 2 late deaths after FloWatch pulmonary artery banding (mean follow-up, 13.4
0.4 months; range, 1–38 months). Postoperative mechanical ventilation and inten-
ive care unit and hospital stays were significantly longer after conventional pul-
onary artery banding than those after FloWatch pulmonary artery banding, re-
pectively (10.4  11.2 vs 3.0  3.1 days [P  .01], 20.3  19.9 vs 5.3  4.6 days
P  .005], and 45.6  41.6 vs 15.4  6.4 days [P  .005]). Reoperation to adjust
he band was required in 7 (35%) of 20 infants after conventional pulmonary artery
anding, whereas no reoperations were required after FloWatch pulmonary artery
anding (P .005). Average cost of stay in the intensive care unit and hospital was,
espectively, $45,000 and $45,300 cheaper with FloWatch pulmonary artery band-
ng than average cost with conventional pulmonary artery banding, largely surpass-
ng the cost of the device ($10,000).
onclusions: FloWatch pulmonary artery banding appears superior to conventional
ulmonary artery banding because (1) reoperations are not required; (2) postoper-
tive management is simplified and postoperative mechanical ventilation, stay in the
ntensive care unit, and stay in the hospital are significantly reduced; and (3) the
eduction in costs of postoperative mechanical ventilation, stay in the intensive care
nit, and stay in the hospital significantly outweigh the cost of the device.
mprovements in the perioperative management of patients with congenital heart
defects have made the surgical repair of most of the intracardiac defects a
clinical possibility, with good outcomes even in small infants.1 Palliation with
ulmonary artery banding (PAB) is nowadays rarely considered for simple congen-
tal heart defects, such as isolated ventricular septal defects. Recent clinical reports
ave considered the PAB for malformations, such as multiple ventricular septal
efects,2 ventricular septal defects associated with aortic arch interruption,2,3 com-
lete atrioventricular septal defects,2,4-7 functionally univentricular hearts,2,5,6,8-10
he Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 6 1413
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Deft ventricular retraining in transposition of the great arter-
es with late referral,11 and congenitally corrected transpo-
ition of the great arteries.12-14 Other indications for PA
nclude hypoplastic left heart malformations, either as a
escue procedure in critically ill neonates or as an elective
reparation for the subsequent operation (ie, either the Nor-
ood procedure to a univentricular repair or heart
ransplantation).15-18
After long-term experimental evaluation in animals,19 a
elemetrically controlled adjustable PAB device, the Flo-
atch PAB device (EndoArt, Lausanne, Switzerland), has
een successfully introduced in clinical practice in different
nstitutions after positive results were obtained in a multi-
enter clinical trial.20-22 This new implantable, wireles
attery-free device demonstrated the feasibility of repeated
rogressive occlusions and reopenings of the device to the
esired percentage of occlusion through a remote control
nit.
The FloWatch PAB device comprises an implantable
evice (Figure 1) and an external control unit. With
evice in the clipped position, the dimensions are as fol-
ows: 26 mm (length)  18 mm (width)  18 mm (height).
he change in the adjustable area is obtained by means of a
iston driven by an incorporated electrical micromotor. The
djustment is done through the external control unit, deliv-
ring the energy to the implanted device through an antenna,
s well as the commands to drive the microengine. The
elemetric system is designed such that the implant sends
ack to the control unit information about its functioning.
hus the FloWatch PAB device allows easy and repetitive
djustable PAB, avoiding the need for reoperation or any
nvasive procedure to adjust the band in both ways.19-22
The clinical introduction of the FloWatch device (com-
ercially available in Europe, having obtained the EC mark
ew years ago) as adjustable PAB has substantially modified
he management of patients with increased pulmonary ar-
ery blood flow and pressure. For indications like Swiss-
heese multiple ventricular septal defects or complete atrio-
entricular septal defects with unbalanced ventricles, the
loWatch PAB allows a fast-track operation, a very reliable
anagement of the pulmonary artery blood flow and pres-
ures in the postoperative period, and the possibility of
elaying the intracardiac repair for much longer than con-
entional banding at the desired age and body weight be-
ause of the ability of reducing the tightness of the band
Abbreviations and Acronyms
conv-PAB conventional pulmonary artery banding
FW-PAB  FloWatch pulmonary artery banding
ICU  intensive care unit
PAB  pulmonary artery bandingith the growth of the patient.
414 The Journal of Thoracic and Cardiovascular Surgery ● DecIn infants with functionally univentricular hearts, the
evice makes possible repetitive titration of pulmonary ar-
ery pressures distal to the narrowing to reach the desired
ow values and later perform a staged cavopulmonary con-
ection. In patients in whom left ventricular retraining is
equired because of late referral in the presence of transpo-
ition of the great arteries and in congenitally corrected
ransposition of the great arteries (ie, double discordance),
loWatch PAB is the only technique that allows modifica-
ions of the distal pulmonary artery pressure in a fashion
uitable with the continuously variable clinical needs of
hese conditions, generally requiring repeated adjustments
nd prolonged stay in the intensive care unit (ICU).11,13,23
On the contrary, FloWatch PAB has never been used for
ilateral banding in hypoplastic left heart syndrome because
ts size precludes the use of 2 devices, one on each branch
f the pulmonary artery.
The clinical experience with this device confirmed in all the
bove situations a substantial reduction of mortality and mor-
idity associated with conventional surgical banding in addi-
ion to a significant reduction in ICU and hospital stay.20-22
Finally, another important advantage of FloWatch PAB
s that at the moment of subsequent intracardiac repair and
ebanding, consisting of unclipping and removal of the
evice, surgical reconstruction of the pulmonary artery is no
onger required.24,25
FloWatch PAB obtains the same reduction of cross-
ectional area as does conventional circular banding and
herefore the same pressure gradient, without any reduction
f the perimeter of the pulmonary artery, as in conventional
anding. By maintaining an intact circumference, with the
ossibility of growth, the wall of the pulmonary artery can
aintain intact its anatomic properties, without any reduc-
ion in elasticity. The simple device removal at the time of
ntracardiac repair is enough to obtain spontaneous and
omplete expansion of the wall of the pulmonary artery,
ith maintenance of its elasticity and pliability.25
Despite the proved clinical advantages, the main criti-
ism from colleagues, hospital administrators, and insur-
nce companies relates to the price of the device ($10,000)
hen compared with a conventional band.
This prospective study, approved by the institutional
thical committee, has been designed to compare the results
btained with conventional pulmonary artery banding
conv-PAB) with those obtained with FloWatch PAB (FW-
AB) in 2 homogeneous groups of infants undergoing PAB
n the same period and the costs related to each treatment
trategy.
aterials and Methods
rom 2003 through July 2006, 40 consecutive infants underwent
ither conv-PAB or FW-PAB. The characteristics of the patient
opulation are presented in Table 1.There were 3 indications for PAB:
ember 2007
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D(1) preparation for a biventricular type of repair (16 [80%] of
20 for conv-PAB and 13 [65%] of 20 for FW-PAB) in
infants with multiple ventricular septal defects, ventricular
septal defect, or atrioventricular septal defect associated
with hypoplasia or interruption of the aortic arch or by the
clinical conditions of the infant (eg, prolonged mechanical s
The Journal of Thoracicventilation with recurrent chest infections and episodes of
respiratory insufficiency);
(2) preparation for a univentricular type of repair (2 [10%] of
20 for conv-PAB and 5 [25%] of 20 for FW-PAB) in
functionally univentricular hearts with pulmonary hyper-
tension; and
(3) left ventricular retraining (2 [10%] of 20 for conv-PAB
and 2 [10%] of 20 for FW-PAB) in infants with transpo-
sition of the great arteries with late referral and in congen-
itally corrected transposition of the great arteries.
The only statistically significant difference (P .005) between the
groups was mean duration of preoperative mechanical ventilation,
hich was 3.3 4.3 days (range, 0–15 days) in the conv-PAB group
nd 17.5  19.0 days (range, 0–60 days) in the FW-PAB group
Table 1).
The assignment of infants to one or the other group has been
ictated by the availability of the device. The availability was
etermined by the initial cost of the FW-PAB device ($10,000).
ecause of the budgetary constraints within our institution, the
evice was only intermittently available for clinical use. When
here were more infant candidates for PAB than devices available,
he FW-PAB device was, in general, reserved for the infants more
ikely to have difficult postoperative management, such as patients
ith prolonged preoperative mechanical ventilation, patients in
reparation for a univentricular type of repair, or both. The final
ecision was always a joint agreement reached during our weekly
epartmental case discussion meeting. All patients were operated
n by one of the 2 surgeons (AFC and MP) and managed during
he entire perioperative period by the same team, according to the
igure 1. A, General view of the FloWatch device. 1, Box with all
he necessary equipment to activate the adjustment mechanism:
small motor, an antenna able to receive the energy, and signals
ent by the external antenna of the FloWatch Control Unit and
lectronics able to extract the energy and to interpret the signal
nd drive the motor. 2, Piston that narrows or releases the
ulmonary artery. 5, Silicone membrane covering the piston. 4,
ounterpiece designed to be closed around the pulmonary artery;
ne side is attached permanently to the box with a hinge (3), and
he other side can be fixed onto the box with a clip (6). Near the
lip is a hole to fix a suture loop (7) useful to pass the counter-
iece behind the pulmonary artery and to clip the device. The
izes of the FloWatch when clipped are 26  18.4  17 mm
length  width  height). B, Top, View of the FloWatch implant
n the completely open position. Middle, Superposed view of a
ompletely open and a maximally closed FloWatch implant. The
iston has a stroke of 3 mm for tightening or releasing the band.
he silicone membrane is flexible and extensible, protecting the
iston and the inside of the case from body fluids while allowing
he piston to perform its adjustment movements. The adjustable
urface where the pulmonary artery is confined varies with the
isplacement of the piston. The 3-mm piston stroke causes a
ariation of the adjustable surface between 72 and 38 mm2 with
reat precision. Bottom, View of the FloWatch implant in the
aximally closed position.ame clinical protocols.
and Cardiovascular Surgery ● Volume 134, Number 6 1415
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DIn both groups the PAB was performed through a median
ternotomy. Conv-PAB was accomplished with a 4-mm Teflon
and, premeasured with the Trusler rule, and adjusted intraopera-
ively according to the measured distal pulmonary artery pressure
nd systemic oxygen saturation. Implantation of the FW-PAB was
erformed by using the same surgical approach for the conv-PAB,
ith simple clipping of the device around the pulmonary artery
nd without intraoperative measurement of the distal pulmonary
rtery pressures but with telemetric adjustments of the device,
uided by means of Doppler echocardiography, after transfer of
he patient to the ICU.
The 2 groups have been compared by collecting the following
ata: (1) early and late deaths; (2) duration of postoperative me-
hanical ventilation and length of stay in the ICU and hospital; (3)
eed for any PAB-related reoperations to tighten, release, or both
he conv-PAB versus need for telemetric adjustments of the FW-
AB to either narrow the device, release the device, or both; and
4) costs of the mean stay in the ICU ($3000 per patient per day)
nd in the hospital ($1500 per patient per day) and costs for
eoperations ($6500 for 1 off-bypass operation).
ABLE 1. Patient population
Conventional
atient no. 20
ean age (range) 1.8 1.5 mo (6
ean weight (range) 3.7 0.7 kg (2.5
revious operation Indication 5/20 (25%
Biventricular repair 16/20 (80%
Univentricular repair 2/20 (10%
LV retraining 2/20 (10%
reoperative mechanical ventilation:
No. 12/20 (60%
Mean duration (range) 3.3 4.3 d (0–1
ssociated procedures 11/20 (55%
AB, Pulmonary artery banding; NS, not significant; LV, left ventricular.
ABLE 2. Results
Conventio
ean follow-up (range) 10.8 9.6 m
eaths
Early 3
Late 2
Total 5/20
ostoperative mechanical ventilation
Mean duration (range) 10.4 11.2 d
tay in ICU
Mean duration (range) 20.3 19.9 d
tay in hospital
Mean duration (range) 45.6 41.6 d
e-do PAB 7/20
ulmonary artery reconstruction at repair 10/12AB, Pulmonary artery banding; NS, not significant; ICU, intensive care unit.
416 The Journal of Thoracic and Cardiovascular Surgery ● DecThe end points of this prospective study were as follows: (1)
eath; (2) debanding (or removal of the device) during the intra-
ardiac repair; and (3) the end of January 2007 for all the remain-
ng patients waiting for intracardiac repair.
The paired Student t test was used for comparisons between the
groups.
esults
he clinical results are presented in Table 2. There w
eaths, 3 early and 2 late, in the conv-PAB group. The early
eaths (1, 15, and 20 days after the operation) occurred
ecause of cardiac arrest during tracheal suctioning, inexo-
able heart failure, and multiorgan failure, whereas the late
eaths (2 and 3 months after the operation) followed sepsis
nd heart failure. There were 2 deaths in the FW-PAB
roup, none early and 2 late (2 and 3 months after the
peration); these deaths followed respiratory infection and
eurologic damage.
FloWatch PAB
Statistical
difference
20 NS
o) 2.6 1.3 mo (7 d–6 mo) NS
kg) 4.1 0.8 kg (2.7–5.7 kg) NS
6/20 (30%) NS
13/20 (65%) NS
5/20 (25%) NS
2/20 (10%) NS
14/20 (70%) NS
17.5 19.0 d (0–60 d) P  .005
11/20 (55%) NS
AB FloWatch PAB
Statistical
difference
33 mo) 13.4 10.4 mo (1–38 mo) NS
0 NS
2 NS
) 2/20 (10%) NS
1 d) 3.0 3.1 d (1–7 d) P  .01
1 d) 5.3 4.6 d (1–20 d) P  .005
82 d) 15.4 6.4 d (6–30 d) P  .005
) 0/20 (0%) P  .005
) 0/7 (0%) P  .0005PAB
d–5 m
–5.5
)
)
)
)
)
5 d)
)nal P
o (1–
(25%
(1–5
(1–5
(5–1
(35%
(83%ember 2007
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DPAB-related reoperation was required in 7 (35%) of 20
nfants after conv-PAB to adjust the band. No reoperations
ere required after FW-PAB (P  .005). There was a mean
f 3.3  1.3 (range, 1–5) telemetric adjustments per infant
o narrow the FW-PAB and 0.7  1.0 (range, 0–3) to
elease it.
During the follow-up period, 19 patients underwent in-
racardiac repair and pulmonary artery debanding, 12 in the
onv-PAB group and 7 in the FW-PAB group. None of
hese 19 patients died. Ten of the 12 patients with conv-
AB required surgical enlargement of the main pulmonary
rtery, with a patch of heterologous pericardium to relieve
esidual stenosis after band removal. No reconstructive pro-
edure of the pulmonary artery was required in all patients
f the FW-PAB group because complete expansion of the
ulmonary artery to its normal size followed removal of the
evice (P  .0005).
At the end of the period of observation, 3 patients in the
onv-PAB group and 12 patients in the FW-PAB group
ere waiting for intracardiac repair.
With regard to the cost calculation (Figure 2), 
onsidering the average cost per patient of ICU ($60,900
n the conv-PAB group and $15,900 in the FW-PAB
roup) and hospital ($68,400 in the conv-PAB group and
23,100 in the FW-PAB group) stay and the average cost
f reoperation ($2275) to adjust the conv-PAB, the av-
rage cost per patient was $92,575 cheaper with FW-PAB
han with conv-PAB, largely surpassing the cost of the
evice ($10,000).
iscussion
n the last decade, PAB as a palliative procedure has largely
een abandoned as a surgical technique in favor of early
igure 2. Cost comparison of the 2 techniques. ICU, Intensive
are unit; PAB, pulmonary artery banding.epair, with exceptions being neonates with functionally p
The Journal of Thoracicniventricular hearts and pulmonary hypertension requiring
reparation for cavopulmonary connections.2,5,6,8-10 More
ecently, the indications for PAB have been revisited or
ccepted as an alternative surgical option in the following:
1) complete atrioventricular septal defects,2,4-7 particularly
n the presence of advanced pulmonary hypertension2,4,7,26;
2) transposition of the great arteries with late referral11 and
ongenitally corrected transposition of the great arteries12-14
n which left ventricular retraining is required; and (3)
ypoplastic left heart malformations as a rescue procedure
n critically ill neonates or as an elective procedure in
reparation for subsequent operations, either the Norwood
rocedure or heart transplantation.15-18 The continued inter-
st in an adjustable PAB has been confirmed also in recent
xperimental27-29 and clinical30 studies of new techniques
The telemetrically adjustable PAB, which is now avail-
ble with the FW-PAB device, an implantable, wireless, and
attery-free device, gives the clinician the ability to repeat-
dly progressively narrow and reopen the pulmonary artery
o a desired percentage of occlusion. Positive results have
ow been obtained in a number of different institutions.20-22
This device provides an adjustable PAB by means of
emote control, avoiding any PAB-related reoperation or
ther invasive procedure to adjust the band either way,
ightening or releasing.19-22 The availability of this surgic
rmamentarium allows an easier management of complex
nfants20-22 and also avoids the pulmonary artery rec-
truction when intracardiac repair is undertaken.24,25
The main criticism of FW-PAB from colleagues, hospital
dministrators, and insurance companies has always been
ts price ($10,000) when compared with that of the conven-
ional band.
Our study of 2 homogeneous groups of patients under-
oing conv-PAB or FW-PAB in the same period of time not
nly confirms the clinical advantages of FW-PAB over
onv-PAB with a significantly shorter and less complicated
ostoperative course but also demonstrates the substantial
eduction of costs with the FW-PAB, greatly outweighing
he initial cost of the device.
imits of the Study
he patients were not randomly selected for either group.
evertheless, the only difference between the 2 groups was
ore difficult management for infants in the FW-PAB
roup because of a larger number of patients in preparation
or a univentricular type of repair and because the duration
f preoperative mechanical ventilation was significantly
onger than in the conv-PAB group.
None of the clinicians involved in caring for the patients
n the perioperative period were blinded with respect to the
ype of PAB used. In our opinion, it was important to
rovide this information in case of urgent need for PAB
and Cardiovascular Surgery ● Volume 134, Number 6 1417
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Ddjustment, either with chest reopening for conv-PAB or
ith the remote control for FW-PAB.
With regard to the cost calculation, only the costs of ICU
nd hospital stay and reoperations have been taken into
ccount. The inclusion of additional costs, such as costs for
he treatment of complications because of a longer stay in
he ICU and hospital and costs for the pulmonary artery
epair, at the time of the intracardiac repair would have
urther increased the difference between the conv-PAB and
W-PAB groups in favor of FW-PAB.
onclusions
he flexibility provided by telemetrically controlled FW-
AB is superior to that of conv-PAB because (1) it elimi-
ates the need for reoperation to adjust the pulmonary artery
and; (2) postoperative management is simplified and post-
perative mechanical ventilation and length of stay in the
CU and hospital are significantly reduced, even in more
ompromised and difficult-to-manage infants; (3) the cost of
he device is more than offset by the reduction in duration of
ostoperative mechanical ventilation, length of stay in the
CU and hospital, and avoidance of any PAB-related reop-
ration; and (4) pulmonary artery reconstruction is no
onger required when intracardiac repair is undertaken.
We thank Gianluca Lucchese for his help in the initial data
ollection and all the colleagues and nurses involved with the
erioperative care of the patients. Pierre Fridez, EndoArt, kindly
rovided the illustrations of the device.
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iscussion
r Cliff K. Choong (Cambridge, United Kingdom). Congratula-
ions on your very good study and results. Based on this, have you
hanged your practice to use this device for all your subsequent
atients?
Dr Corno. First of all, we now can use this device in any
atient because the hospital administration is convinced that, de-
pite the initial cost, we can spare the money.
Regarding the management, we changed a lot of policies. For
nstance, patients with multiple ventricular septal defects are now,
n the neonatal period, treated with this device. Now we have a
roup of 5 patients, on average 2 to 3 years after surgical inter-
ention, and we follow all of them. Of course, when the patient
rows and the body weight increases, we can release the device to
void the right ventricular pressure becoming suprasystemic. And
n 4 patients all multiple ventricular septal defects, 2½ to 3 years
fter surgical intervention, underwent spontaneous closure. Two
eeks ago, I operated on one patient, removing the device, and
ithout anything else required, even the pulmonary artery recon-
truction was not necessary. Much easier is the management, of
ourse, of a univentricular heart, for obvious reasons, because you
an titrate the distal pulmonary artery pressure as you want based
n echocardiographic results. In the group for left ventricular
etraining, we have only 4 patients, but the number is increasing
nd, of course, in the future, with this device available for left
entricular retraining.
Mr Choong. Second, do you recommend that all pediatric
urgeons should now be using this rather than conv-PAB?
Dr Corno. Yes. It changes from the night to the day.
Mr Choong. Lastly, the device seems to be flawless. Are there
ny short- or long-term complications associated with this device?
Dr Corno. We have found complications with this device
aused by the fact that the piston is covered by a silicone mem-
rane to prevent damage to the pulmonary artery. We had one
omplication in one of the animals in the clinical study and in 2
atients, one in another center and one in our center, because if you
o close to the membrane with any sharp instrument, like a needle
r knife, you can produce a hole in the membrane, the pericardial
uid enters into the device, and then the micromotor stops work-
ng. Then you remain with a conventional banding.
Dr Renato Assad (Sao Paulo, Brazil). First of all, I would like
o congratulate Dr Corno and his colleagues for the very ingenious
loWatch and his work on adjustable PAB.
I would like to share with the association the first case in which
high-risk neonate with hypoplastic left heart syndrome was
nitially managed with a miniadjustable PAB system in both pul-
onary arteries. The banding system is entirely silicone covered,
miniaturized and improved device developed from our previous
xperimental studies that resulted in a more delicate banding
ystem for neonatal use with a 4-mm diameter. Ten percutaneous t
The Journal of Thoracicdjustments of the banding system were necessary to keep the
rterial oxygen saturation in the 75 to 85 range before the second
tage. The Norwood operation and bidirectional Glenn shunt were
arried out on the 106th day of life, and the total cavopulmonary
onnection was carried out in the 21st month of life. There was no
ulmonary artery distortion after removing the bands.
The clinical use of this innovative PAB system allowed for a
ustomization of the pulmonary blood flow according to the un-
erlying clinical needs, resulting in a more precise balance be-
ween the pulmonary and systemic circulations.
I have a question for Dr Corno regarding the left ventricular
etraining patient. How was the length of time comparing the 2
ystems?
I thank the association for the opportunity to make these
omments about your new prototype.
Dr Corno. Thank you, Dr Assad, for the question. Of course I
m familiar with your article, and I can tell you at the moment that
here is no indication of using this device when you need a bilateral
anding. The first reason is the size of the device, and the second
s the cost. You will need to do another study and have discussions
ith the hospital administrators.
To answer your question, the interval depends on the adapt-
bility of the new system. We follow this with echocardiography,
nd we want, of course, to obtain almost systemic pressure in the
ew systemic ventricle. From a study done when I was in Lau-
anne,11 we calculated with the echocardiographic analysis the
atio between the thickness of the free wall of the right ventricle
ersus the left ventricle. When you have reached the inversion of
he ratio, it means that we have reached a high enough level of left
entricular hypertrophy or hyperplasia according to the age of the
hild, and then we can go for the arterial switch operation.
Dr Pedro Becker (Santiago, Chile). That was very interesting,
ntonio, but what bothers me is that I do not find here the key end
oint that you are pursuing when you band the pulmonary artery.
o me, mortality is such a gross end point. Pulmonary artery bands
re designed to either decrease pulmonary artery pressure, limit
p/Qs, or retrain the left ventricle. Therefore I think it would be
ery interesting to really know whether the goals of the PAB were
roperly accomplished with this device in a better way than the
onventional technique and therefore convince us surgeons not to
se just the regular PAB any more. Congratulations, anyway.
Dr Corno. Thank you. First of all, you can discuss the
ndication for banding versus repair. These patients, in our
xperience, were without indication for a repair because either
hey were in for a univentricular type of repair (and you cannot
erform a cavopulmonary connection in the first weeks of life)
r in for left ventricular retraining. In case of biventricular
epair, we had patients with unbalanced complete atrioventric-
lar septal defect, multiple ventricular septal defects, ventricu-
ar septal defect with aortic coarctation, and hypoplasia of the
ortic arch. Most patients were referred after 1 or 2 months in
he ICU on mechanical ventilation. In our experience these
atients did not constitute a good indication for banding. Then
ou have to decide between a conventional banding and an
djustable banding. The main difference is the management in
he immediate postoperative course.
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DWith a fixed band, either you have to go back and reopen the chest
or 3 times, particularly when you need for univentricular heart or left
entricular retraining, whereas with this device you can simply go in420 The Journal of Thoracic and Cardiovascular Surgery ● Decand and close the chest, and you do all the adjustments after the
peration. You can do it progressively within days or weeks, and this
s much better tolerated than the conventional banding, when youhe operating room, perform a much faster procedure, and clip the have to suddenly change the hemodynamics.ember 2007
